Platform
Features
Pricing
1 follower
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
Industries
Headquarters
Employees
Links
Full screen
Douglas Thomson
View all
5 people · 0 jobs
HQ
2 positions, 0 job posts
QuellTX
4 followers
ORCHA
FUJIFILM Diosynth Biotechnologies
16 followers
Merck
277 followers
Diabetes UK
5 followers
Amicus Therapeutics
Ramsay Health Care UK
Revvity
8 followers
myPOS
6 followers
AtriCure
Abbott
373 followers
Explore companies